Yes, humans can take trazodone, and it is the same active drug found in pet formulations, but pet trazodone should never be used as a substitute for a human prescription. The drug is FDA-approved for depression in people and used off-label for insomnia and anxiety, while veterinary use is off-label for behavioral disorders. The danger is not the molecule but the dose, the tablet size, and the lack of human-specific labeling. A single 100 mg pet tablet can equal a full starting human dose, and larger dog tablets reach 300 mg, which exceeds the usual human starting range.
The Same Molecule in Two Different Worlds
Trazodone hydrochloride is a serotonin antagonist and reuptake inhibitor, often abbreviated SARI. It blocks serotonin 5-HT2A and 5-HT2C receptors while weakly inhibiting serotonin reuptake. That dual action explains its unusual profile: sedation at low doses, antidepressant effect at higher doses, and sleep improvement in between. The molecule does not change between a human pharmacy and a veterinary clinic.
What changes is everything around the molecule. Human trazodone is manufactured in scored tablets of 50 mg, 100 mg, and 150 mg, and in extended-release forms of 150 mg and 300 mg. Veterinary trazodone is compounded or sold as 50 mg, 100 mg, and 150 mg tablets, but the dosing schedule is weight-based for dogs and cats, not humans. Per the FDA's 2019 approval of trazodone for human depression, the labeled starting dose is 150 mg per day divided into two doses. A 50-pound dog may receive 100 to 150 mg as a single pre-visit dose. Those numbers overlap, which is exactly why people assume the drugs are interchangeable.
In plain terms: the pill bottle looks the same, but the instructions behind it were written for a different species.
Mechanism: Why Trazodone Sedates Dogs and Humans Alike
Trazodone's sedative effect comes from its blockade of histamine H1 and alpha-1 adrenergic receptors. Both species share these receptors, so the drowsiness translates directly. The antidepressant effect depends on sustained serotonin reuptake inhibition, which builds over two to four weeks in humans. Dogs do not receive trazodone for depression, so the chronic serotonin mechanism is largely irrelevant in veterinary behavioral use.
A non-obvious detail: trazodone's metabolite, m-chlorophenylpiperazine, or mCPP, is a serotonin agonist that can cause anxiety and restlessness in some patients. This is why a small minority of humans report paradoxical agitation on trazodone rather than calm. The same metabolite forms in dogs, which is one reason veterinarians watch for increased anxiety rather than assuming sedation will occur.
The half-life is roughly 7 to 10 hours in humans and 2 to 4 hours in dogs. That difference matters for redosing. A dog may clear the drug in under half the time a human does, so a pet owner who borrows a dog's tablet and redoses on the dog's schedule could overdose. Conversely, a human who takes a dog-sized dose and waits the human half-life may hold a much higher blood level for much longer than intended.
Quantified Comparison: Human vs. Pet Trazodone
The table below reconciles the thresholds that most often confuse people. Human starting dose is 150 mg per day; human maximum is 400 mg per day for outpatients and 600 mg per day for inpatients per the 2019 FDA label. Veterinary doses run 2 to 10 mg per kilogram, which for a 50-pound dog equals 45 to 227 mg per dose, and doses can be repeated every 8 to 12 hours.
| Feature | Human trazodone | Pet trazodone |
|---|---|---|
| Approved indication | Major depressive disorder | None; off-label behavioral use |
| Typical starting dose | 150 mg/day, divided | 2 to 10 mg/kg per dose |
| Maximum labeled dose | 400 mg/day outpatient | Variable; often 10 mg/kg |
| Half-life | 7 to 10 hours | 2 to 4 hours |
| Common tablet sizes | 50, 100, 150, 300 mg | 50, 100, 150 mg |
| Primary risk in wrong species | Serotonin syndrome, priapism | Sedation, ataxia, agitation |
| Liver metabolism | CYP3A4 | CYP3A4, similar pathway |
The key reconciliation: a 100 mg pet tablet is below the 150 mg human daily starting dose but above it if split into two 50 mg halves, and a 300 mg dog tablet equals 75 percent of the 400 mg outpatient ceiling. No single pet tablet is automatically safe or automatically dangerous; the number on the label must be matched to the human's prescribed milligrams, not to the animal's weight.
Timeline: What Happens After Taking Trazodone
The time course differs by species and by formulation. The table below reflects immediate-release tablets, the form most pet owners encounter.
| Time after dose | Human effect | Dog effect |
|---|---|---|
| 0 to 30 minutes | Minimal; absorption begins | Onset of sedation in 30 to 60 minutes |
| 30 to 60 minutes | Peak plasma near 1 to 2 hours | Peak sedation near 1 hour |
| 1 to 2 hours | Drowsiness, dry mouth | Deep sedation, possible ataxia |
| 2 to 6 hours | Sedation persists | Waning sedation; redose window opens |
| 6 to 12 hours | Gradual decline | Most drug cleared |
| 12 to 24 hours | Residual grogginess | Minimal residual effect |
| 24 to 48 hours | Full clearance in most adults | Full clearance |
The practical implication: a human who takes a pet tablet and feels nothing at 30 minutes should not assume it failed. Peak human plasma concentration arrives closer to 1 to 2 hours, and the sedative effect can lag behind absorption. Redosing early is the most common overdose pattern in borrowed-pet-medication cases.
Edge Cases: Who Is at Highest Risk
Several groups face disproportionate risk from any trazodone exposure, pet-sourced or otherwise. Adults over 65 clear the drug more slowly and are more prone to orthostatic hypotension and falls. People taking SSRIs, SNRIs, or MAOIs face serotonin syndrome risk from additive serotonergic load. Per the 2019 FDA label, trazodone is contraindicated with MAOIs and should be used cautiously with other serotonergic drugs.
Priapism is a rare but serious adverse effect, reported in roughly 1 in 1,000 to 1 in 10,000 male users, and it is a medical emergency requiring treatment within 4 hours. Liver impairment slows CYP3A4 metabolism and raises blood levels. Pregnancy and breastfeeding lack adequate human data, so pet-sourced exposure during pregnancy is especially unwise.
A corrected misconception: many people believe pet medications are "gentler" because they are made for animals. In reality, veterinary trazodone tablets are often the same milligrams as human tablets, and compounded versions may vary in potency by 10 to 20 percent because they are not held to the same uniformity standards as FDA-approved human products.
Red Flags: When to Seek Emergency Care
Stop and call poison control or emergency services if any of the following occur after taking trazodone, whether prescribed or borrowed.
- A painful erection lasting more than 4 hours, which is priapism and a urologic emergency.
- Agitation, tremor, sweating, or fever above 100.4 F, which may signal serotonin syndrome.
- Fainting, a heart rate above 120 beats per minute, or a sustained drop in blood pressure.
- Confusion, hallucinations, or severe drowsiness that prevents safe swallowing.
- Vomiting, abdominal pain, or signs of liver injury such as yellowing eyes within 48 hours.
For human exposures, the American Association of Poison Control Centers can be reached at 1-800-222-1222, and the call is free and available 24 hours a day.
What to Actually Do: Safe Steps
The safest path is a human prescription, not a borrowed tablet. If a person has taken pet trazodone, the actions below reduce risk and clarify the situation.
Confirm the exact milligram on the pet label and compare it to the human's prescribed dose before deciding anything. Do not split a pet tablet to improvise a human dose, because scored veterinary tablets are not guaranteed to divide evenly. Call a pharmacist or poison control with the tablet strength, the time taken, and any other medications. Watch for the red flags above for at least 12 hours. Store pet medications separately from human medications, ideally in a locked box, because accidental ingestion is the leading route of pet-drug exposure in adults. If insomnia or anxiety is the underlying reason for borrowing the drug, ask a clinician about human-labeled options such as melatonin, cognitive behavioral therapy for insomnia, or a prescribed sedating antidepressant.
Limitations and the Bottom Line
Established science supports trazodone as an effective human antidepressant and a common off-label sleep aid, and it supports veterinary behavioral use under supervision. What remains uncertain is the exact risk of one-time pet-tablet exposure in a healthy adult, because controlled studies do not exist for that scenario. The numbers above are drawn from labeled dosing, pharmacokinetic studies, and case reports, not from trials of cross-species borrowing. The conservative reading is simple: the molecule is the same, the margin is not. A pet tablet can be a human dose or a human overdose depending on the milligram, so the label and a clinician's input decide the outcome, not the fact that the drug is sold for dogs.